Reuters logo
BRIEF-Inventiva and AbbVie extend agreement
2017年9月4日 / 早上6点27分 / 18 天前

BRIEF-Inventiva and AbbVie extend agreement

Sept 4 (Reuters) - INVENTIVA SA:

* INVENTIVA AND ABBVIE EXTEND AGREEMENT TO DISCOVER NEW POTENT ORALLY-AVAILABLE SMALL MOLECULE RORΓ INVERSE AGONIST DRUG CANDIDATES

* INVENTIVA WILL RECEIVE AN UNDISCLOSED RESEARCH PAYMENT‍​

* INVENTIVA WILL RECEIVE MILESTONE PAYMENTS WHEN A NEW CANDIDATE IS IDENTIFIED‍​

* INVENTIVA WILL ALSO BE ELIGIBLE FOR DEVELOPMENT AND SALES MILESTONES AS WELL AS ROYALTIES ON SALES‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below